carbamylhydrazine has been researched along with T-Cell Lymphoma in 1 studies
carbamylhydrazine: RN given refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marttila-Ichihara, F | 1 |
| Castermans, K | 1 |
| Auvinen, K | 1 |
| Oude Egbrink, MG | 1 |
| Jalkanen, S | 1 |
| Griffioen, AW | 1 |
| Salmi, M | 1 |
1 other study available for carbamylhydrazine and T-Cell Lymphoma
| Article | Year |
|---|---|
Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice.
Topics: Adjuvants, Immunologic; Allylamine; Amine Oxidase (Copper-Containing); Animals; Antibodies, Blocking | 2010 |